Special Issue "Antidiabetic Drugs"
QuicklinksA special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 June 2010)
Special Issue Editor
Guest Editor
Prof. Dr. Kailash Prasad
Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
E-Mail:
Phone: +1 306 966 6539
Interests: Oxygen radicals, antioxidants, heart failure, atherosclerosis, diabetes, flaxseed and its components, hypertension, hypercholesterolemia, acute coronary syndrome, advanced glycation end products, soluble receptor for advanced glycation end products, C-reactive protein, homocysteine, cytokines, phosphoenolpyruvate carboxykinase
Published Papers
Special Issue Information
Submission
All manuscripts should be submitted to pharmaceuticals@mdpi.com with a copy to the Guest Editor. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
Keywords
- insulin
- exenatide
- pramlintide
- sulfonylurea
- meglitinides
- biguanides
- thiazolidinediones
- glucagon-like peptide (GLP) analogs and agonists
- DPP-4 inhibitors
- amylin analogues
- gastric inhibitory peptide (GIP) analogs
Last update: 13 August 2010